Close
Search
Close

To get the team

Head of Life Sciences Practice

What he specialises in

Konstantin has more than 10 years of experience in law, for 8 of which he has been providing legal assistance to pharmaceutical companies in Russia and the CIS. He specialises in transactions with assets in the area of pharmaceuticals, solving complex regulatory issues, including those connected with intellectual property of pharmaceutical companies, with the localisation of manufacturing in Russia, and with advertising and other methods of promoting pharmaceutical products.

Konstantin has vast experience of representing clients in negotiations, and within the framework of complaint proceedings and in litigation, including disputes with supervisory authorities.

His key achievements

Among Konstantin’s major projects are:
  • provided successful legal support for a major transaction on the market of Russia and the CIS with respect to the disposal of a portfolio of medicines, and other transactions with assets in Russia and the CIS;
  • provided legal support for transfers of the production of medicines from production sites in the EU to production sites in Russia;
  • was actively involved in the development of recommendations to apply legislation on advertising of OTC medicines adopted by major associations of pharmaceutical producers under the auspices of the FAS (the Russian Federal Antimonopoly Service);
  • prepared legal opinions on various issues related to launching generic drugs on the market, and registering biologically active supplements and medical products;
  • developed and implemented commercial and credit policies of a pharmaceutical company in Russia and the CIS.

What they say

Pepeliaev Group's team exhibits “excellent value for money and a result-oriented approach”. (Legal 500)
02.06.2021
Pepeliaev Group has joined international employment law association L&E Global
Read more
24.05.2021
Pepeliaev Group at the St. Petersburg International Legal Forum 9 ¾: summary of events
Read more
29.04.2021
Konstantin Sharlovskiy is heading Pepeliaev Group’s life sciences practice
Read more

Вход | Регистрация

E-mail

Click here to subscribe our English newsletters